ORCHID PHARMA
|
The Current P/S Ratio of ORCHID PHARMA is 4.11.
Share Price | ₹747.4 | Jul 03,2025 |
Market Cap | ₹3,789.3 Cr | |
Sales-TTM | ₹921.9 Cr | TTM-Consolidated Results |
Price/Sales | 4.11x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of ORCHID PHARMA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹3,789.3 Cr] as on Jul 03,2025
(/) Sales [ ₹921.9 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 4.11x ]
Thus, for ORCHID PHARMA , the investors are currently willing to pay '4.11 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of ORCHID PHARMA !
The chart below summarizes the trend in P/S Ratio of ORCHID PHARMA over the last five years.
Historical PS (Price/Sales) ratio chart of ORCHID PHARMA
PS Ratio Performance Analysis for ORCHID PHARMA
- ORCHID PHARMA 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 6.65x.
- ORCHID PHARMA 's operated at median p/e ratio of 2.36x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ORCHID PHARMA 's p/e ratio peaked in Mar2021 at 22.36x.
- ORCHID PHARMA 's p/e ratio hit its five-year low in Mar2020 of 0x.
How does ORCHID PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
ORCHID PHARMA | 921.9 | 4.11 | 3,789.3 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 52,578.4 | 7.66 | 402,788.0 |
DIVIS LABORATORIES LTD | 9,360.0 | 19.47 | 182,283.0 |
CIPLA LTD | 27,547.6 | 4.42 | 121,853.0 |
TORRENT PHARMACEUTICALS LTD | 11,516.0 | 9.80 | 112,914.0 |
DR REDDYS LABORATORIES LTD | 32,643.9 | 3.31 | 107,932.0 |
MANKIND PHARMA LTD | 12,279.3 | 7.94 | 97,548.4 |
ZYDUS LIFESCIENCES LTD | 23,241.5 | 4.33 | 100,563.0 |
LUPIN LTD | 22,707.9 | 3.93 | 89,315.4 |
AUROBINDO PHARMA LTD | 31,723.7 | 2.12 | 67,114.5 |
ABBOTT INDIA LTD | 6,409.2 | 11.76 | 75,397.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs ORCHID PHARMA 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.12x |
Max industry PS | 19.47x |
Median industry PS | 4.42x |
Average industry PS | 7.17x |
You may also like the below Video Courses